IRINOCYT 40 MG/2ML
IRINOTECAN
Public price
533,00 MAD
Reimbursement base
533,00 MAD
Active substance
IRINOTECAN
Reimbursable
What is this medicine?
A topoisomerase inhibitor and derivative of camptothecin that prevents the religation of single-strand DNA breaks, resulting in double-strand DNA damage during synthesis.
Verified summary
IRINOTECAN, SOLUTION A DILUER POUR PERFUSION, 40 MG, 1 FLACON 2 ML
Common uses
Treatment of metastatic carcinoma of the colon or rectum, used as first-line therapy in combination with 5-fluorouracil and leucovorin, or for patients whose disease has recurred or progressed following initial fluorouracil-based therapy.
Class
Topoisomerase inhibitor
Availability note
Reimbursable
Hospital price
354,00 MAD
Strength
40 MG
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
1 FLACON 2 ML
Type
G
Therapeutic class
ANTINEOPLASIQUE CYTOTOXIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 533,00 MAD
Available presentations and strengths
Medicines with the same active substance
IRINOTECAN
40 MG · 1 BOITE 1 FLACON
0,00 MAD
IRINOTECAN
100 MG · 1 BOITE 1 FLACON
0,00 MAD
IRINOTECAN COOPER
100 MG / 5 ML · BOITE DE 1
1,10 MAD
IRINOTECAN KABI
20 MG / ML · FLACON DE 5 ML
1,17 MAD
CAMPTO
100 MG / 5 ML · FLACON DE 5 ML
1,31 MAD
TECAN
100 MG / 5 ML · FLACON DE 5 ML
1,31 MAD
IRINOTECAN VIATRIS 20 MG / ML
20 MG · 1 flacon de 2 ml
450,00 MAD
IRINOTECAN ZENITH 40 MG / 2 ML
40 MG / 2 ML · Flacon de 2 ml
499,00 MAD
IRINOTECAN RANBAXY 40 MG / 2 ML
40 MG / 2 ML · Flacon de 2 ml
505,00 MAD
IRINOTECAN COOPER
40 MG · 1 FLACON 2 ML
506,00 MAD
IRINOTECAN COOPER
40 MG / 2 ML · BOITE DE 1
506,00 MAD
IRINOTECAN KABI
20 MG / ML · FLACON DE 2 ML
506,00 MAD